GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,450 | +1.7% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,426 | +14160.0% | 40 | -85.9% | 0.00% | -80.0% |
| Q1 2023 | $10 | +11.1% | 283 | +16.5% | 0.01% | +25.0% |
| Q4 2022 | $9 | -99.9% | 243 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $7,000 | -53.3% | 243 | -69.8% | 0.01% | 0.0% |
| Q2 2022 | $15,000 | -16.7% | 804 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $18,000 | -10.0% | 804 | 0.0% | 0.01% | -22.2% |
| Q4 2021 | $20,000 | -16.7% | 804 | 0.0% | 0.01% | -18.2% |
| Q3 2021 | $24,000 | +100.0% | 804 | +164.5% | 0.01% | +83.3% |
| Q2 2021 | $12,000 | +9.1% | 304 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $11,000 | 0.0% | 304 | +1.3% | 0.01% | 0.0% |
| Q4 2020 | $11,000 | -69.4% | 300 | -68.4% | 0.01% | -75.0% |
| Q3 2020 | $36,000 | +33.3% | 950 | +46.2% | 0.02% | +17.6% |
| Q2 2020 | $27,000 | -12.9% | 650 | 0.0% | 0.02% | -15.0% |
| Q4 2019 | $31,000 | – | 650 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |